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ABSTRACT 
We have computationally investigated the use of the multi-segment, multi-addition, plug-flow 
crystallizer (MSMA-PFC) for use in producing pharmaceutical crystals. A population balance 
framework was used to model the crystallization process. The dissolution of crystals can be 
modeled when solubility is below saturation. The evolved volume fraction distributions were 
optimized in a least-squares sense by manipulating a vector of decision variables in order to hit a 
target volume fraction distribution. The genetic algorithm was used for optimization. A reduced 
orthogonal array experimental design was used to examine the effect of several kinetic 
parameters and total crystallizer length. The results indicate that the parameters which govern 
nucleation are the most sensitive, followed by those for growth. Dissolution does not appreciably 
occur in any of the optimizations. The reason the optimization does not add any pure solvent is 
likely due to the addition of pure solvent causing a simultaneous decrease in concentration and 
decrease in residence time, which the optimization judges to be sub-optimal. 
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1. Introduction 
1.1 Continuous crystallization 
Continuous crystallization of pharmaceuticals has attracted much interest in recent years as a 
cheaper, more efficient alternative to batch-wise purification.1–5 This is part of an overall much 
broader research effort aimed at developing fully continuous pharmaceutical manufacturing 
systems, including reactors, crystallizers, granulators, and tableting machines – among others.6–9 
Crystallization is of special interest due to its ubiquity in pharmaceuticals – over 80% of active 
pharmaceutical ingredients (API) are purified by crystallization.10 The process is widely used in 
the agrochemical and fine chemicals industries as well. 11,12 
1.2 Motivation for In-Situ Removal of Fine Crystals 
While purification is the main motive behind crystallization, the crystal size distribution (CSD) 
affects downstream operations and the ameliorative properties of the final dosage form. The 
curative properties of the final dosage form are dependent on the dissolution rate and 
bioavailability, which are strongly affected by the CSD and other particle properties.13,14 
Downstream processes affected by CSD shape include filtering, washing, and drying.15 The 
presence of fine crystals greatly encumbers these operations. 
The typical method of removing fines is to classify the product crystals, re-dissolve the fines, 
separate the antisolvent when feasible, and recycle the mixture back to the crystallization system. 
However, this method is problematic. Classification, recycle, and stream separation require 
further process equipment, increasing capital and operating costs. Classification combined with 
recycle has been mathematically deduced (and subsequently observed) to impart oscillatory 
dynamics to the CSD12. These oscillations make it difficult to obtain a consistent product. 
Furthermore, from a risk analysis viewpoint, extra equipment is generally “more things that can 
go wrong”, and presents another route by which microbes could contaminate the manufacturing 
process. It would be good if we could eliminate fines altogether by an in-situ approach. 
1.3 Prior Work on In-Situ Fines Removal 
Previous work by Abu Bakar et al. and Majumder and Nagy explored the concept of “in-situ” 
fines removal, where the operation of the crystallizer actively eliminates fine crystals during the 
crystallization by means of dissolution.13,16 With this approach, classification, re-dissolving, and 
stream separation are rendered (in theory) unnecessary. The work by Majumder and Nagy most 
closely follows our work here. 16 In that work, a constrained nonlinear optimization problem was 
solved to identify temperature profiles that would match a target distribution in a least-squares sense by 
removing fine crystals. 
1.3.1 Cooling Crystallization versus Antisolvent Crystallization: The Coupling of Antisolvent 
Addition with Concentration and with Residence Time 
Majumder and Nagy previously investigated computationally the use of a multi-segment cooling 
crystallizer for in-situ fines dissolution.16 In that work, the decision variables were the jacket 
temperatures in each segment, which allowed the particular segment to go above or below 
solubility as necessary to dissolve the fine crystals and grow large ones. Ridder et al. have 
modeled and optimized a multi-segment antisolvent crystallizer for drug crystal production, but 
that work did not allow for dissolution to occur. 17,18 This work is an extension of the previous 
works by Ridder et. al. and Majumder and Nagy, as we are now using an antisolvent 
crystallization with the capability to dissolve crystals when below solubility.16  Figure 1 below 
depicts the path of information flow for a cooling PFC crystallization process, and an antisolvent 
PFC crystallization process. For an antisolvent crystallization, the decision variables are the 
flowrates of antisolvent into each segment. As can be seen in the figure, there is no coupling 
between concentration and residence time in the cooling crystallization. Residence time 
furthermore, is always constant. 
In the antisolvent case however, the addition of solvent reduces the current concentration via 
dilution. Also, residence time decreases monotonically with each successive segment. As we 
shall see further ahead, this coupling dramatically increases the difficulty of optimization and the 
performance of the crystallizer. 
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Figure 1.  Information flow diagrams in a multisegment crystallizer for (a) cooling crystallization and (b) 
antisolvent crystallization. The cooling crystallization has no coupling between residence time and the control 
(jacket temperature), and residence time is constant within each segment. None of this is true in antisolvent 
crystallization, since the addition of antisolvent simultaneously affects the current concentration via dilution, and 
reduces the current residence time due to a mass balance argument. 
1.4 Parametric Study via Optimization of the Antisolvent Crystallizer 
In this work, we present results for the steady-state operation of a multi-segment, multi-addition, 
plug-flow crystallizer MSMA-PFC which utilizes dissolution to eliminate fine crystals. We have 
explored the geometric design parameters of the crystallizer, as well as the kinetic parameters of 
crystallization. To reiterate, this work is an extension of that by Majumder and Nagy, but for the 
case of antisolvent crystallization as opposed to a cooling crystallization.16 
2. Multiple segment, multiple-addition antisolvent plug flow crystallizer (MSMA-PFC) 
Model Framework 
2.1 Model Diagram 
 
Figure 2. Diagram of the multi-segment, multiple-addition plug flow crystallizer (MSMA-PFC). Seeded liquid 
solvent, with solute concentration 𝐶0 flows in from the left into a mixing chamber (gray box). The dilution 
correction factor, 𝛾𝑗, is applied to the exit stream around each mixing point (red dashed boxes). The combined 
streams then flow into a plug-flow segment (blue rectangle). Antisolvent reduces solubility, triggering nucleation 
and growth. Streams of pure solvent are utilized to push the solution below solubility when necessary. 
The MSMA-PFC is based on the setup in Alvarez and Myerson.2 It is modeled as a series of 
ideal plug flow elements, of equal length, and antisolvent is added at the beginning of each 
segment (Figure 2 above). Each of the N segments is a separate PFC, running in steady-state, 
isothermal operation. The inlet stream (at the far left) feeds saturated mother liquor at flowrate 
𝑉𝑓𝑒𝑒𝑑 (ml/min), with an initial concentration of solute, 𝐶0 (kg API/kg solution), and a seed CSD, 
𝑛0 (# of crystals/kg of solution∙m). At each mixing point (gray boxes in the figure) antisolvent 
flowing at flowrate 𝐴𝑗 (ml/min) and pure solvent at flowrate 𝑆𝑗 (ml/min), mixes together with the 
main stream for 𝑗 = 1,2, … , 𝑁. It is to be noted that we are using mass-intensive units for our 
state variables, 𝑛 (# of crystals/kg of solution∙m) and 𝐶 (kg API/kg solution). 
2.2 Summation Indices and Segment Indices 
Summation indices always use the letter 𝑖 as a dummy index. The letter 𝑗 always refers to “for 
the 𝑗𝑡ℎ PFC segment.” When an index refers to a mixing point, 𝑗 always refers to the mixing 
point immediately preceeding the 𝑗𝑡ℎ PFC segment (e.g. the 𝑗 = 1 mixing point is the very first 
mixing point on the left hand side in Figure 2 above). 
2.3 Effect of Dilution 
The addition of streams 𝐴𝑗 and 𝑆𝑗 to the process causes a decrease in 𝐶 and 𝑛 in the oncoming 
feed stream due to the effect of dilution. Concentration and number density are reduced because 
the solute mass (and crystal mass) has remained the same, but total volume has increased. There 
is a double meaning of this term in the literature, as some authors refer to antisolvent 
crystallization as “dilution.”12 We reiterate that in this paper, we refer to dilution as being the 
reduction in solute concentration due to the addition of a solute-free liquid at a constant solute 
mass. To account for this effect, the number density of the 𝑗𝑡ℎ outgoing stream, 𝑛𝑗  (# of 
crystals/kg of solution∙m) about the jth mixing point is multiplied by: 
 γ𝑗 =  
𝜌𝑗
𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛𝑉𝑗
𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛
𝜌𝑗+1
𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛𝑉𝑗+1
𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛
 (1) 
Where 𝜌𝑗
𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛 is the density of the solution, and 𝑉𝑗 is the volumetric flow rate of the entire 
stream. 𝑉𝑗
𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛 can be determined by dividing the total solution mass flow rate by the total 
solution density: 
 𝑉𝑗+1
𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛 =  
𝜌𝐻2𝑂(𝑉𝑓𝑒𝑒𝑑 + ∑ 𝑆𝑖
𝑗
𝑖=1 ) + 𝜌𝐸𝑡𝑂𝐻 ∑ 𝐴𝑖
𝑗
𝑖=1  
𝜌𝑗+1
𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛
 (2) 
Where 𝜌𝐻2𝑂 and 𝜌𝐸𝑡𝑂𝐻 are the densities of water as solvent and ethanol as antisolvent (997 kg/m
3 
and 785.22 kg/m3, respectively). The total solution density, 𝜌𝑗+1
𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛 (kg/m3), is calculated 
numerically from a curve fit of the density of an ethanol-water mixture in terms of ethanol mass 
fraction. These expressions are derived by performing progressively wider mass balances about 
the mixing points and PFC segments. The method is more easily explained with a diagram 
(Figure 3 below). The colored boxes demonstrate the pattern one follows to ultimately derive (1) 
and (2). 
 
Figure 3. Mass balance envelopes that are used to derive γ dilution correction factor. Incoming streams are 
positive; outgoing are negative. 
After mixing with the solvent and antisolvent streams, the mixture then flows into the 𝑗𝑡ℎ PFC segment, 
where nucleation and growth occur. We assume the streams mix on a time scale well below the induction 
time, and also attain plug-flow. At the exit of the segment, a new size distribution, 𝑛(𝐿, 𝑥𝑗
𝑒𝑛𝑑), and a 
reduced solute concentration, 𝐶(𝑥𝑗
𝑒𝑛𝑑), are obtained. We will abbreviate these quantities as 𝑛𝑗
𝑒𝑛𝑑 and 
𝐶𝑗
𝑒𝑛𝑑. We clarify to the reader that this is not the same as 𝐶𝑗+1 or 𝑛𝑗+1; these quantities are created when 
the next solvent and antisolvent streams are added; the pattern of indexing is made clear in Figure 2 
above. This process continues recursively until the product stream leaves the final, 𝑁𝑡ℎ segment (product 
stream). The final crystal size distribution, 𝑛𝑁
𝑒𝑛𝑑, is used for solving the least-squares optimization 
problem. Both 𝑛𝑁
𝑒𝑛𝑑 and 𝐶𝑁
𝑒𝑛𝑑 are used to calculate several constraints. 
3. Crystal Population and Solute Mass Balance Equations 
Simulation of isothermal antisolvent crystallization processes requires two governing equations 
to be solved simultaneously: the population balance equation, and the mass balance equation. 
3.1 Population Balance Equation 
Population balances are a mathematical framework for tracking the properties of large 
populations of entities. Such balances are routinely used in the modeling of crystallization 
processes for the purpose of tracking size (though other properties, such as composition and 
shape, can also be plausibly tracked in this way).The first is the population balance equation for 
solving for the crystal size distribution: 
 𝑢𝑥,𝑗
𝜕𝑛𝑗
𝜕𝑥
+ 𝐺𝑗
𝜕𝑛𝑗
𝜕𝐿
=  𝐵0,𝑗𝛿(𝐿 − 𝐿0) (3) 
Where 𝑢𝑥 is the average velocity in the x-direction of the fluid (m/s), 𝑛 is the crystal size 
distribution (#/kg of solution∙m), 𝑥 (m) is the length along the crystallizer, 𝐺 (μm/s or m/s) is the 
linear crystal growth rate, 𝐿 (m or μm) is the characteristic crystal length, 𝐵0 is the nucleation 
rate (# of nucleated crystals/kg solution∙s), and 𝛿(𝐿 − 𝐿0) (m
-1) is the Dirac delta function, which 
mathematically describes the assumption that nucleated crystals come into existence with size 
𝐿0. 𝐿 is referred to as the “internal coordinate” since it deals with the properties of entities within 
the control volume, while 𝑥 is the “external coordinate”, since it is a location in physical space 
within the control volume. We have assumed simple one-dimensional flow in our pipe, hence 
why there is only one external coordinate. We believe the assumption of 1-D flow to be valid, 
given that the Reynolds number for the flows studies was typically in excess of 9000. The 𝑗 
subscript always refers to the value of a quantity in the 𝑗𝑡ℎ PFC segment. 
The average velocity in the x-direction in the 𝑗𝑡ℎ segment is computed by dividing volumetric 
flow rate by the cross-sectional tube area: 
 𝑢𝑥,𝑗 =
𝑉𝑗
𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛
𝜋𝑑𝑖𝑛𝑛𝑒𝑟
2 4⁄
 (4) 
Where 𝑑𝑖𝑛𝑛𝑒𝑟 is the inner diameter of the crystallizer tube, which is the same for all segments. 
3.2 Definition of Moment 
The 𝑘𝑡ℎ-moment of the crystal size distribution in the 𝑗𝑡ℎ PFC segment is defined by: 
 𝜇𝑘,𝑗 = ∫ 𝑛𝑗𝐿
𝑘𝑑𝐿
∞
0
 (5) 
With units of (mk/kg solution). The interpretation of the first several moments (per kg solution) 
are: 
 𝜇0: The total number of crystals. 
 𝜇1: Measure of the total end-to-end-length of the crystals. 
 𝜇2: Measure of the total interfacial surface area of the crystals exposed to the solution. 
 𝜇3: Measure of the total volume of the crystals. 
3.3 Mass Balance Equation 
The other equation is the mass balance for dissolved drug: 
 
𝑑𝐶𝑗
𝑑𝑥
= −
𝜌𝑐𝑘𝑣
𝑢𝑥,𝑗
(3𝐺𝜇2,𝑗 + 𝐵0,𝑗𝐿0
3) (6) 
The term 𝜇2 is the second moment of the crystal size distribution (m
2 of crystals/kg solution). 𝐶 
is the solute concentration in the liquid phase (kg API/kg solution), 𝜌𝑐 is the density of 
crystalline API (assumed to be 1490 kg/m3), 𝐿0 is the minimum detectable crystal size (m), 𝐵0 is 
the nucleation rate (# of nucleated crystals/kg solution∙s), and 𝑘𝑣 is the dimensionless crystal shape 
factor (𝜋/6 for spheres) 19.  In a pure mathematical treatment, 𝐿0 would simply be set to zero; however, 
all instrumentation used in practice for experimentation and process control will have limits to 
observability. Equation (6) is an integro-differential equation, since 𝜇2 is defined by the integral 
expression (5). 
3.4 Boundary Conditions 
For the first segment (𝑗 = 1), the boundary conditions for these equations are: 
 
𝑛1(𝐿, 𝑥 = 0) =γ1𝑛0 
𝑛1(𝐿 = 0, 𝑥) = 𝐵0,1 𝐺1⁄  
𝐶1(𝑥 = 0) =γ1𝐶0 
(7) 
Where 𝑛0 is the crystal size distribution of the seed crystals, 𝐵0 is the nucleation rate (#/kg of 
solution∙s), and 𝐶0 is the initial solute concentration. In subsequent segments (𝑗 ≥ 2), the 
boundary conditions become: 
 
𝑛𝑗(𝐿, 𝑥 = 0) =γ𝑗𝑛𝑗−1
𝑒𝑛𝑑 
𝑛𝑗(𝐿 = 0, 𝑥) = 𝐵0,𝑗 𝐺𝑗⁄  
𝐶𝑗(𝑥 = 0) =γ𝑗𝐶𝑗−1
𝑒𝑛𝑑 
(8) 
A Gaussian bell curve was used for 𝑛0 (#/kg of solution∙m) in all cases, with mean 𝛿𝑠𝑒𝑒𝑑 (m) and 
standard deviation 𝜔𝑠𝑒𝑒𝑑 (m): 
 𝑛0(𝐿) =
𝑁𝑡𝑜𝑡𝑎𝑙
𝜔𝑠𝑒𝑒𝑑√2𝜋
exp (−
(𝐿 − 𝛿𝑠𝑒𝑒𝑑)
2
2𝜔𝑠𝑒𝑒𝑑2
) (9) 
Where 𝑁𝑡𝑜𝑡𝑎𝑙 is the total number density (# of crystals/kg solution). 𝑁𝑡𝑜𝑡𝑎𝑙 can be interpreted in 
(9) as a constant that forces the seed distribution to agree with the specified seed mass loading, 𝜆 
(%, dimensionless). The mass balance on the seed distribution is closed by solving the algebraic 
equation for 𝑁𝑡𝑜𝑡𝑎𝑙 such that: 
 𝜆𝐶0 − 𝜌𝑐𝑘𝑣𝜇3,0 = 0 (10) 
where 𝜇3,0 is the third moment of the seed distribution. Equation (10) is closed by manipulating 
𝑁𝑡𝑜𝑡𝑎𝑙, which is embedded in the integral term 𝜇3,0: 
 𝜇3,0 = ∫ 𝑛0𝐿
3𝑑𝐿
∞
0
 (11) 
 
3.5 Growth, Nucleation, and Dissolution Rate Laws 
The growth and nucleation laws are given by the equations (again, all 𝑗 subscripts refer to the 𝑗𝑡ℎ 
segment): 
 
𝐺𝑗(𝑆𝑗) = 𝑘𝑔𝜎𝑗
𝑔, 𝐵0,𝑗(𝜎𝑗) = 𝑘𝑏𝜇2𝜎𝑗
𝑏 , 𝐷𝑗(𝜎𝑗) = −𝜑𝑘𝑔(1 − 𝜎𝑗)
𝑑 
𝜎𝑗 = 𝐶𝑗(𝑥)/𝐶𝑠𝑎𝑡,𝑗 
(12) 
where 𝜎 is the supersaturation ratio, 𝑘𝑔 is the growth rate constant (m/s), 𝑔 is the growth rate 
order, 𝑘𝑏 is the nucleation rate constant, 𝑏 is the nucleation order, 𝐷 is the dissolution rate (m/s), 
𝑑 is the dissolution order, and 𝐶𝑠𝑎𝑡 is the solubility concentration (kg API/kg solution). 𝐺 is 
replaced by 𝐷 in (3) for 𝜎 <  1. 
We use a modified version of the growth law for the dissolution rate law. The dissolution rate 
can be approximated by multiplying the modified version of the growth law by a constant 𝜑 > 1, 
which adjusts for the fact that dissolution is typically much faster than growth. The calculation of 
𝐶𝑠𝑎𝑡 is discussed in section 3.6 below.  The values of the kinetic parameters are taken from 
experimental work by Luo et al. and are included in Table 1.19 These parameters were chosen 
because they are expressed in terms of water mass fraction, which is significantly easier to work 
with than other representations. 
Table 1.  Physical and chemical property data table used for modeling the antisolvent crystallization. 
Parameter Value 
Initial concentration, 𝐶0 
[kg API/kg solution] 
0.030935 
Shape factor 𝑘𝑣, [-] π/6 
Solid API density 𝜌𝑐, 
[kg/m3] 
1490 
Dissolution 
acceleration, 𝜑 [-] 
250 
Number of segments, 𝑁 
[-] 
50 
Seed crystal mean size, 
𝛿𝑠𝑒𝑒𝑑  [μm] 
50 
Seed crystal standard 
deviation, 𝜔𝑠𝑒𝑒𝑑 [μm] 
10 
 
3.6 Calculation of API Solubility 
The solubility of the API in a water-ethanol (solvent-antisolvent) mixture at 25 ℃ was taken 
from the experimental data plot provided in Figure 2 of Luo et al. 19 for the case of the drug 
biapenem. Data points were extracted from the curve, and are given in  
Table 2 below. Comparison with various curve fitting methods in MATLAB showed that linear 
interpolation provided the best fit. The data correspond to a minimum solubility in ethanol as 
2.464 mg/ml, and a maximum solubility in water as 30.935 mg/ml. 
 
Table 2. Solubility data for biapenem-water-ethanol system at 25 ℃. 
Water Mass Fraction, 
Xw 
Csat x 103 (kg solute/kg 
solution) 
0.199 2.464 
0.299 2.831 
0.398 3.497 
0.500 4.463 
0.599 6.103 
0.699 9.615 
0.799 15.299 
0.898 21.956 
1.000 30.935 
 
The water mass fraction in the 𝑗𝑡ℎ PFC is computed by: 
 𝑋𝐻2𝑂
𝑗 =
𝜌𝐻2𝑂𝑉𝑓𝑒𝑒𝑑 + 𝜌𝐻2𝑂 ∑ 𝑆𝑖
𝑗
𝑖=1
𝜌𝐻2𝑂𝑉𝑓𝑒𝑒𝑑 + 𝜌𝐻2𝑂 ∑ 𝑆𝑖
𝑗
𝑖=1 + 𝜌𝐸𝑡𝑂𝐻 ∑ 𝐴𝑖
𝑗
𝑖=1
 (13) 
Plugging 𝑋𝐻2𝑂
𝑗
 into the curve fit object created in MATLAB yields the solubility concentration 
of biapenem, 𝐶𝑠𝑎𝑡,𝑗. 
3.7 Solution of Model Equations 
A typical method used for solving equations (3) and (6) is to apply the method of moments 
(MOM), which reduces system to a small number of coupled ordinary differential equations for 
the moments of the crystal size distribution. However, this method is useless here, since we need 
the full CSD to be able to match the target distribution. Previous researchers have attempted 
various deconvolution/inversion methods in the moments to re-construct the crystal size 
distribution, but these methods tend to yield poor results and be more trouble than they are 
worth.20 A variety of methods have been developed for direct solution of the population balance 
equation. To solve this system, we have utilized a high-resolution finite volume (FV) technique, 
which is the combination of the semi-discrete FV technique with the van Leer flux limiter.16,21 
This method provides 𝑂(ℎ2) accuracy where the solution is smooth, without the oscillations 
found in other methods. Details on the finite volume method are given in Majumder and Nagy.16  
Equation (3) was discretized into 𝐾 ordinary differential equations, where 𝐾 is the number of 
crystal size bins. The discretization started at 1 μm, and marched upward up to the maximum bin 
size of 500 μm, for a total of 𝐾 = 101 bins. Equations (3) and (6) are solved simultaneously, 
with the sixth-order accurate Boole’s Rule used to approximate 𝜇2 in (6). The method marches 
forward into external space, using 10 steps in external space. 
4. Optimization Problem Formulation 
Our goal is to eliminate the production of fine crystals by utilizing dissolution. The quality of the 
elimination is ascertained by measuring how closely the attained volume fraction distribution 
leaving the 𝑁𝑡ℎ PFC (𝑓𝑣,𝑁,𝑒𝑛𝑑) matches a theoretically-best growth-only volume fraction 
distribution, 𝑓𝑣,𝑡𝑎𝑟𝑔𝑒𝑡. The target distribution is generated by simulating the crystallization with 
only one segment, with nucleation arbitrarily set to zero. With no nucleation, all solute depletion 
is solely due to crystal growth on the seeds, and no fine crystals are ever created. Thus, the target 
distribution is a hypothetical best-case scenario of pure growth achieved without nucleation. The 
closeness of matching can be expressed in a least-squares sense. By manipulation of the 
antisolvent and solvent flowrates in each segment (and other decision variables), we can make 
the fit between the model and the target distribution tighter. 
Equations (3) and (6) are solved for each segment, and the output of one segment recursively 
becomes the input to the next segment. The procedure begins anew, with fresh antisolvent and 
pure solvent flowing into the main flow stream. Population density and solute concentration are 
adjusted for the dilution induced by addition of solvent and antisolvent at each mixing point. 
 
4.1 Least-Squares Objective Function 
The final volume fraction distribution, 𝑓𝑣,𝑁,𝑒𝑛𝑑, is used for formulating the least-squares 
problem: 
 
𝑚𝑖𝑛
𝒅
∑(𝑓𝑣,𝑁,𝑒𝑛𝑑
𝑖 − 𝑓𝑣,𝑡𝑎𝑟𝑔𝑒𝑡
𝑖 )
2
𝐾
𝑖=1
 
𝑠. 𝑡. Model equations 3 − 13 
 constraints (discussed later) 
 
(14) 
Where 𝒅 is the vector of 2𝑁 + 5 decision variables, and 𝑓𝑣,𝑁,𝑒𝑛𝑑 is the volume fraction size 
distribution at the exit of the crystallizer. It is computed as: 
 𝑓𝑣,𝑁,𝑒𝑛𝑑 =
𝑛𝑁
𝑒𝑛𝑑𝐿3
∫ 𝑛𝑁
𝑒𝑛𝑑𝐿3
∞
0
𝑑𝐿
 (15) 
The index 𝑖 in (14) refers to a particular crystal size bin, with 𝐾 total bins. Note that 𝑛 integrates 
to 𝑛𝑡𝑜𝑡𝑎𝑙 (the total number of crystals in the solution), while 𝑓𝑣,𝑁,𝑒𝑛𝑑 integrates to 1. We use the 
volume fraction distribution instead of the number density, since the addition of extra solvent 
and antisolvent causes dilution.  
4.2 List of Decision Variables and Bound Constraints 
All 2𝑁 + 5 decision variables in these optimizations had bound constraints. Table 3 below 
summarizes the decision variables and their lower/upper bounds.  
 
 
Table 3. Decision variables and bound constraints for in-situ fines dissolution optimization. 
Decision 
Variable 
Title Units 
Lower 
Bound 
Upper 
Bound 
𝑉𝑓𝑒𝑒𝑑 Feed flowrate of saturated solvent [ml/min] 0 300 
𝐴𝑡𝑜𝑡𝑎𝑙 Total flowrate of antisolvent [ml/min] 0 300 
𝑆𝑡𝑜𝑡𝑎𝑙 Total flowrate of pure solvent [ml/min] 0 150 
𝑑𝑖𝑛𝑛𝑒𝑟 Inner diameter of crystallizer tube [m] 10 × 10
−3 25 × 10−3 
𝜆 Seed mass loading [%] 2% 7% 
𝑎1, 𝑎2, … , 𝑎𝑁 Antisolvent distribution fractions [-] 0 1 
𝑠1, 𝑠2, … , 𝑠𝑁 Pure solvent distribution fractions [-] 0 1 
 
The optimization of the MSMA-PFC is known to be highly non-convex, as shown by the 
landscape plots in Ridder et al.17 Such problems are not amenable to gradient search, and so we 
have opted for a stochastic approach to circumvent the nonconvexity. The genetic algorithm 
(GA) is a popular tool for solving optimization problems with this kind of difficulty. To make 
the GA operate more smoothly, our decision variables were fractions of the total antisolvent and 
total pure solvent. The flowrate into a segment 𝑗 is the 𝑗𝑡ℎ fractional distribution variable 
multiplied by total flow allotment. 
 
 
𝐴𝑗 = 𝑎𝑗𝐴𝑡𝑜𝑡𝑎𝑙  
𝑆𝑗 = 𝑠𝑗𝑆𝑡𝑜𝑡𝑎𝑙 
(16) 
 
4.3 Linear and Nonlinear Constraints 
There were no linear inequalities in this study. The only linear constraints in this work are two 
equalities, which require the apportionments of total liquid flows must each sum to unity. The 
remaining four constraints are nonlinear inequalities. Table 4 below summarizes these 
constraints. 
Table 4. Linear and nonlinear constraints for in-situ fines dissolution optimization. 
Name Constraint Description Type 
𝑐1 
∑ 𝑎𝑖
𝑁
𝑗=1
= 1 
 
Total fractions of added liquid flows must sum to unity. Linear 
𝑐2 
∑ 𝑠𝑖
𝑁
𝑗=1
= 1 
 
𝑐3 𝜎𝑁
𝑒𝑛𝑑 − 1.05 ≤ 0 Final supersaturation is bracketed between 0.5 and 1.05. 
 
 
Nonlinear 
𝑐4 0.5 − 𝜎𝑁
𝑒𝑛𝑑 ≤ 0 
𝑐5 𝜏𝑡𝑜𝑡𝑎𝑙 − 3600 ≤ 0 Total residence time under 3600 seconds (1 hour). 
𝑐6 0.30 − 𝑌 ≤ 0 Minimum required crystal mass yield of 30%. 
 
In the multiple-cooling segment PFC array, residence time is constant, since flowrate of liquor 
into each segment is always the same. However, the addition of antisolvent and pure solvent to 
the liquor flow changes residence time into a nonlinear function: 
 𝜏𝑡𝑜𝑡𝑎𝑙 = ∑ 𝜏𝑗
𝑁
𝑗=1
=
𝜋𝑑𝑖𝑛𝑛𝑒𝑟
2 (𝑥𝑡𝑜𝑡𝑎𝑙/𝑁)
4
∑
1
𝑉𝑓𝑒𝑒𝑑 + 𝐴𝑡𝑜𝑡𝑎𝑙 ∑ 𝑎𝑖
𝑗
𝑖=1 + 𝑆𝑡𝑜𝑡𝑎𝑙 ∑ 𝑠𝑖
𝑗
𝑖=1
𝑁
𝑗=1
 (17) 
Where 𝑥𝑡𝑜𝑡𝑎𝑙/𝑁 is the length of a single segment. The 𝑗
𝑡ℎ summand in (17) is the residence time 
for the 𝑗𝑡ℎ segment, which is the segment’s volume divided by the total flow rate through that 
segment. The total residence time is found by summing over all 𝑗 individual residence times. 
Since each PFC segment’s volume is the same, it is taken out of the summation distributively. 
Yield is calculated in the following manner: 
 𝑌 =
𝑉𝑓𝑒𝑒𝑑𝜌𝐻2𝑂𝐶0 − (𝑉𝑓𝑒𝑒𝑑𝜌𝐻2𝑂 + 𝑆𝑡𝑜𝑡𝑎𝑙𝜌𝐻2𝑂 + 𝐴𝑡𝑜𝑡𝑎𝑙𝜌𝐸𝑡𝑂𝐻)𝐶𝑁
𝑒𝑛𝑑
𝑉𝑓𝑒𝑒𝑑𝜌𝐻2𝑂𝐶0
 (18) 
If 𝐶𝑁
𝑒𝑛𝑑 = 0, then all of the solute has been crystallized, and thus 𝑌 = 1. If no crystallization has 
occurred, the numerator will be zero, and thus 𝑌 = 0. If seed crystals have been dissolved due to 
excessive dissolution, then 𝑌 can become negative. 
5. Solution of Least-Squares Problem by the Genetic Algorithm 
5.1 Nonconvexity of Search Space 
The genetic algorithm is an optimization algorithm based on the theory of natural selection. 
Briefly, solutions to the optimization problem are filtered by starting with a large initial 
“population”, and judging their “fitness” in terms of the score they output when substituted into 
the objective function. “Unfit” candidates are eliminated from the gene pool, while the survivors 
have “children” with each other by various genetic operators of crossover and mutation. This 
process repeats itself for several “generations” or until a certain tolerance threshold on the 
objective function is satisfied. More complexity arises when constraints are introduced into the 
problem. The GA is less efficient compared to gradient-based methods, such as sequential 
quadratic programming (SQP). However, algorithms like SQP are not robust to initial guess, and 
can become trapped in a sub-optimal local minimum.22,23 This is true when the objective function 
and/or constraints are non-convex. Stochastic methods, such as the GA or simulated annealing, 
are appropriate for nonconvex optimization. 
5.2 Genetic Algorithm Solution 
The problem was solved by manipulating the 2𝑁 + 5 decision variables with the genetic 
algorithm (GA). The initial population was created by randomly sampling over the bounds given 
in Table 3. The number of injections was arrived at through trial and error. The number of 
injections could not be used as a decision variable, as MATLAB’s current genetic algorithm 
cannot solve mixed-integer nonlinear programming (MINLP) problems that have any type of 
equality constraint. The number of injections used was 50, which gave a good tradeoff between 
curve fit and computation time. The population size was 750, repeated for up to 25 generations. 
The MATLAB integrator, depending on the particular run, was chosen for the quickest solution 
time. Either ode45, ode15s, or ode23 were used. 
6. Results and Discussion 
To investigate the crystallizer’s performance for various kinetic parameters and total lengths, a 
reduced orthogonal array experimental design was used, with five factors, four levels, and 16 
total runs. The five factors are the nucleation and growth parameters, and the total crystallizer 
length. The five factors and the four levels used are shown in Table 5 below. 
Table 5. Table of the five factors and four levels used for examining parameter space. 
Level 
Nucleation rate constant, 
𝒌𝒃 [#/m
2∙s] 
Nucleation order, 
𝒃 [-] 
Growth 
rate 
constant 
𝒌𝒈 [μm/s] 
Growth 
order 𝒈 
[-] 
Total length 
of crystallizer, 
𝒙𝒕𝒐𝒕𝒂𝒍 [m] 
1 1 × 106 1 0.1 1 5 
2 1 × 107 2 0.5 1.333 10 
3 1 × 108 3 1 1.667 15 
4 1 × 109 4 5 2 20 
 
A reduced design was used, since exhaustive search over 45 = 1024 different optimizations was 
computationally prohibitive. This experimental table is given in Table 6. The orthogonal array 
table allows for a good sampling of the parameter space with only 16 samples instead of 1024. 
 
Table 6. Experimental design table of factors and levels for the curve fit optimizations conducted. 
The numbers correspond to the level column in Table 5. The sum of the squares of the errors (SSE) 
and total amount of pure solvent added (𝑺𝒕𝒐𝒕𝒂𝒍) are given for each run. 
Run # 𝒌𝒃 𝒃 𝒌𝒈 𝒈 𝒙𝒕𝒐𝒕𝒂𝒍 SSE 𝑺𝒕𝒐𝒕𝒂𝒍 
1 1 1 1 1 1 2.67E+07 80 
2 1 2 2 2 2 4.71E+06 0 
3 1 3 3 3 3 1.25E+07 1 
4 1 4 4 4 4 7.58E+05 1 
5 2 1 2 3 4 5.62E+08 3 
6 2 2 1 4 3 7.42E+08 0 
7 2 3 4 1 2 2.25E+07 2 
8 2 4 3 2 1 6.93E+07 0 
9 3 1 3 4 2 2.22E+09 8 
10 3 2 4 3 1 2.10E+08 2 
11 3 3 1 2 4 6.08E+09 0 
12 3 4 2 1 3 3.10E+09 9 
13 4 1 4 2 3 3.41E+09 11 
14 4 2 3 1 4 7.82E+09 24 
15 4 3 2 4 1 8.28E+09 25 
16 4 4 1 3 2 1.27E+10 16 
 
Table 6 above shows the experimental design matrix, as well as the resulting sum of the squared 
errors for each curve fit to the zero-nucleation target distribution. 
6.1 Volume Fraction Distributions for Optimized Cases 
The data in Table 6 show that run #1 gave the tightest curve fit (Figure 4). The reason for this 
tight curve fit is due to the system exhibiting low nucleation (the 𝑘𝑏 level is at the lowest level). 
Also in Figure 4. we show the performance of a single segment with nucleation turned back on 
(𝐵0 > 0). We can see there is little improvement observed between MSMA-PFC and using a 
single segment. 
 Figure 4. Volume-fraction distribution for run #1. 
Increasing values of 𝑘𝑏 rapidly degrade the curve fit due to overwhelming nucleation. Run #11 is 
representative of runs which are nucleation-dominated. As shown in Figure 5, there is a large 
amount of fines created, and the optimal result fails to hit the target distribution. While we have 
improved the volume fraction distribution over the single-segment case by producing less fines 
at the exit, there is still a great deal of fines produced. The nucleation rate constant has the 
greatest effect upon the performance of the crystallizer, indicating significant sensitivity to 
nucleation rate. 
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 Figure 5. Volume-fraction distribution for run #11, a nucleation-dominated case. 
6.2 Main-Factor Analysis 
The results in section 6.1 suggest to us that the best results, intuitively, are obtained when the 
system is growth-dominated. Main-factor analysis of the experimental matrix confirms this 
suspicion. Main-factor analysis is done by taking the average of all SSE for a given factor at the 
same level. For example, the average for the factor 𝑘𝑏 at level 2 would take the average SSE over 
runs 5, 6, 7, and 8. This process is repeated for all five factors and all four levels, which 
generates Table 7 below. 
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Table 7.  Level-wise averages of SSE for each corresponding level and factor pair. 
 
𝒌𝒃 𝒃 𝒌𝒈 𝒈 𝒙𝒕𝒐𝒕𝒂𝒍 
L1 1.12E+07 1.56E+09 4.89E+09 2.74E+09 2.15E+09 
L2 3.49E+08 2.20E+09 2.99E+09 2.39E+09 3.74E+09 
L3 2.90E+09 3.60E+09 2.53E+09 3.38E+09 1.82E+09 
L4 8.06E+09 3.97E+09 9.11E+08 2.81E+09 3.62E+09 
 
This analysis reveals to us what the most sensitive parameters are, and also what set of levels 
will provide the best curve fit – which we hypothesized would be the growth-dominated case. 
We can see in Table 7 that the factor 𝑘𝑏 spans the widest range of SSE values over the level 
averages. We thus conclude that 𝑘𝑏 is the most sensitive parameter. Following the same line of 
reasoning, the second-most sensitive parameter is 𝑘𝑔. The optimal curve fit is projected to be the set of 
levels for which SSE is a minimum for each corresponding factor. These values are shown in boldface in 
Table 7 (they are the minimum values within each column). The main-factor analysis projects that the 
tightest curve fit will be observed at a 𝑘𝑏 of level 1, a 𝑏 of level 1, a 𝑘𝑔 of level 4, a 𝑔 of level 2, and 
an 𝑥𝑡𝑜𝑡𝑎𝑙 of level 3. We term this the “projected optimum.” Note that this set of factors and levels is not 
present in Table 6. Solving the optimization problem with this new set of parameters generates the 
volume fraction distributions in Figure 6, which had an SSE of 4.83 × 105, which is less than the 
minimum of 7.58 × 105 in Table 6. 
 
 Figure 6. Optimal fit predicted by analysis of the orthogonal array design. 
This result matches our intuition that the best result is obtained when nucleation is slow and 
growth is fast. However, this has the effect of “cancelling out” the benefits of using multiple 
injections, as we obtain a very tight fit to the curve anyways when using a single injection for 
this set of kinetic parameters. There was no discernible trend observed with respect to the 
optimized tube diameter. However, seed loading was typically between 5.0%-6.5%. 
6.3 No Dissolution is Used to Control Fines 
It is interesting (even if a bit disappointing) to observe that the optimization does not want to use 
dissolution to get rid of fine crystals. The total amount of pure solvent added during each 
optimization is given as the rightmost column in Table 6. Observe that little to no pure solvent is 
ever added to the system for the optimal curve fits (observe in Table 3 that 𝑆𝑡𝑜𝑡𝑎𝑙is bounded on 
the left by zero). The supersaturation ratio profiles (𝜎 vs. 𝑥 plots) show barely any dissolution 
occurring. The supersaturation profile for the “project optimum” is representative (Figure 7). 
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 Figure 7. Supersaturation profile for project optimum, representative of the other supersaturation profiles. 
Note how the supersaturation does not significantly (or at all) go below 1 anywhere in Figure 7. 
This indicates to us that the situations in which the curve fit is superior to the single-segment 
case (Figure 4 and Figure 5) is more likely due to the better control offered by using multiple 
segments (and thus having finer control over supersaturation), rather than making use of fines 
dissolution. The reason the optimization refuses to add pure solvent in significant amounts is due 
to the fact that adding pure solvent reduces the concentration (via dilution) and reduces available 
residence time (via equation (17)). Reduced concentration reduces the available supersaturation, 
and reducing the residence time reduces the time available for growth inside the MSMA-PFC. 
Thus, despite the potential for dissolving fines, the benefit of adding pure solvent does not 
counterbalance the other two negative phenomena. 
7. Summary and Conclusions 
We have investigated the optimal operation of antisolvent crystallization in a MSMA-PFC and 
explored the feasibility of dissolution steps by addition of pure solvent in order to dissolve the 
fine crystals in-situ.  The model equations solved were the population balance equation and the 
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integro-differential mass balance equation. The solution method used was the finite volume 
method, since the entire CSD was required to calculate the sum of the squared errors for the 
curve fit. The final CSD was compared to a target CSD generated by arbitrarily setting 
nucleation to zero. A reduced orthogonal array experimental design was used to examine the 
effect of several kinetic parameters and total crystallizer length. The genetic algorithm was used 
to optimize over the decision variables, with the parameters from the experimental design table 
held constant. The results indicate that 𝑘𝑏 is the most sensitive parameter, followed by 𝑘𝑔. As 𝑘𝑏 
increases, the curve fit degrades rapidly due to becoming overwhelmed by nucleation. 
Examination of the supersaturation profiles shows that dissolution is not occurring appreciably 
for any of the optimizations performed. The MSMA-PFC performs best under kinetic 
crystallization conditions in which a single PFC also works sufficiently well. There are situations 
where using multiple additions does improve the curve fit versus the single-segment case, but 
excessive fines still exist. The reason the optimization does not add any pure solvent is likely due 
to the addition of pure solvent causing a simultaneous decrease in concentration and decrease in 
residence time. Both of these cause the optimization to take “one step forward and two steps 
back”, thus adding pure solvent is judged to be sub-optimal. 
 To implement this system in practice, several sensors and control loops would be 
necessary. A variety of low-cost sensors have been developed in recent years.24 The paper by 
Simon et. al. 25 reviews the state of the art with regards to sensors, but only a few are feasible for 
use in this system. Ultrasonic crystallization monitoring (UCM) is only applicable for crystal 
sizes of at least 100 microns, which is too large for most of the crystals simulated in this study. 
Conductometry measurements for concentration are only feasible if the compound being 
crystallized is inorganic. Raman spectroscopy is only necessary if a shift in polymorphic form in 
expected. 
 The most likely candidates for CSD monitoring are either/or focused beam reflectance 
measurement (FBRM) and video imaging, as well as FTIR for measurement of concentration. 
However, even these techniques may only be practical for the larger crystals, thus allowing only 
a portion of the crystal size distribution to be measured. FBRM signals would need to be 
adjusted, as FBRM only measures chord length distribution, and not crystal size distribution. The 
continuous nature of the crystallization suggests also a continuous approach to data collection. 
Data from these sensors can be viewed as a continuous stream of complex information, which 
requires sophisticated algorithms to process for accurate state estimation. Such methods are 
reviewed in Simon et. al.25 
 For feedback control, the likely measured variables would be the CSD and concentrations 
at the exit of the crystallizer array, which would then feedback to flow controllers for the 
dispensation of solvent and antisolvent. Adjustment of flow rates to the individual segments 
would function as feedback actuation method. Comparison between the expected CSD and 
measured CSD, and expected concentration and measured concentration, would drive the 
feedback control. A more complicated approach would be to have CSD and concentration 
sensors in between each crystallizer segment, thus providing much more information on the 
evolution of the CSD as a function of length. Flow controllers could then respond much faster to 
process disturbances, as crystals would not need to flow all the way to the exit of the crystallizer 
before controller action is taken. Feedforward control also seems like a likely necessity, as the 
properties of the input seed crystals may not be uniform in time, and thus represent a disturbance 
at the inlet of the process. Fluctuations in inlet concentration are also possible, requiring further 
additional control. 
 Some comparison with the previous work by Majumder and Nagy is in order.16 That 
work is very similar to this work. In both cases, crystallization is being optimized in a least-
squares sense by manipulating process parameters in order to hit a target distribution. In that 
work however, temperature was the method for altering supersaturation, whereas in this case we 
used antisolvent to alter liquid-phase composition (and hence, the supersaturation). One of the 
key differences between that work and this work, is that temperature cycling is observed to be 
the optimal strategy for the elimination of fine crystals. It was observed in that work further that 
the efficacy of the optimization was significantly enhanced if the crystallization and dissolution 
kinetics were size-dependent. We have not considered size-dependency in this work, which may 
be a worthwhile subject of future investigation. 
Nomenclature 
Symbol Meaning Units 
𝑎1, 𝑎2, … , 𝑎𝑁 Proportion of total antisolvent allocated to the 
𝑗𝑡ℎ segment  
- 
𝐴 Antisolvent flowrate ml/min 
𝐴𝑡𝑜𝑡𝑎𝑙  Total flowrate of added antisolvent summed 
over all segments 
ml/min 
𝑏 Nucleation order - 
𝐵0 Nucleation rate # of nucleated crystals/kg 
solution∙s 
𝐶 Solute concentration kg API/kg solution 
𝐶0 Initial concentration of solute kg API/kg solution 
𝐶(𝑥𝑗
𝑒𝑛𝑑) or 𝐶𝑗
𝑒𝑛𝑑 Solute concentration at the end of the 𝑗𝑡ℎ 
segment 
kg API/kg solution 
𝐶𝑁
𝑒𝑛𝑑 Solute concentration at the exit of the kg API/kg solution 
crystallizer 
𝐶𝑠𝑎𝑡 Solubility (saturation) concentration kg API/kg solution 
𝑑 Dissolution order - 
𝒅 Vector of decision variables varies 
𝑑𝑖𝑛𝑛𝑒𝑟 Inner diameter of crystallizer tube m 
𝐷 Crystal linear dissolution rate m/s 
𝑓𝑣 Volume fraction distribution m
-1 
𝑓𝑣,𝑁,𝑒𝑛𝑑 Volume fraction distribution at the exit of the 
crystallizer 
m-1 
𝑓𝑣,𝑡𝑎𝑟𝑔𝑒𝑡 Target volume fraction distribution m
-1 
𝑔 Growth rate order - 
𝐺 Crystal linear growth rate μm/s or m/s 
𝑖 Dummy summation index - 
𝑗 Index corresponding to the 𝑗𝑡ℎ crystallizer 
segment 
- 
𝐾 Total number of crystal size bins - 
𝑘𝑏 Nucleation rate constant # of nucleated crystals/m
2∙s 
𝑘𝑔 Growth rate constant m/s 
𝑘𝑣 Crystal shape factor, 𝜋/6 - 
𝐿 Internal coordinate; characteristic crystal length m or μm 
𝐿0 The smallest crystal size bin μm 
𝑛 Number density (crystal size distribution) # of crystals/kg of solution∙m 
N Number of crystallizer segments - 
𝑛0 Seed crystal size distribution # of crystals/kg of solution∙m 
𝑛(𝐿, 𝑥𝑗
𝑒𝑛𝑑) or 𝑛𝑗
𝑒𝑛𝑑 Number density at the end of the 𝑗𝑡ℎ segment # of crystals/kg of solution∙m 
𝑛𝑁
𝑒𝑛𝑑 Crystal size distribution at the exit of the 
crystallizer 
# of crystals/kg of solution∙m 
𝑁𝑡𝑜𝑡𝑎𝑙 Total number density of crystals # of crystals/kg solution 
𝑆 Pure solvent flowrate ml/min 
𝑠1, 𝑠2, … , 𝑠𝑁 Proportion of total pure solvent allocated to the 
𝑗𝑡ℎ segment 
- 
𝑆𝑡𝑜𝑡𝑎𝑙 Total flowrate of added pure solvent, summed 
over all segments 
ml/min 
SSE Sum of the squared errors varies 
𝑢𝑥 Average velocity in the x-direction m/s 
𝑉𝑓𝑒𝑒𝑑 Saturated mother liquor at flowrate ml/min 
𝑉𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛 Volumetric flowrate of entire solution stream, 
containing both solvent and antisolvent 
ml/min 
𝑥 External coordinate; distance along a crystallizer 
segment 
m 
𝑋𝐻2𝑂 Mass fraction of water - 
𝑥𝑡𝑜𝑡𝑎𝑙 Total length of the entire crystallizer m 
𝑌 Crystal mass yield - 
Greek Symbols   
γ Dilution correction factor - 
𝛿(𝐿 − 𝐿0) Dirac delta function, with pulse centered at 𝐿0 m
-1 
𝛿𝑠𝑒𝑒𝑑  Mean of seed distribution Gaussian bell curve m 
𝜆 Seed mass loading % 
𝜇𝑘 𝑘
𝑡ℎ-moment of the crystal size distribution mk/kg solution 
𝜌𝑐 Density of solid API crystals kg/m
3 
𝜌𝐸𝑡𝑂𝐻 Density of ethanol kg/m
3 
𝜌𝐻2𝑂 Density of water kg/m
3 
𝜌𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛 Density of solution kg/m3 
𝜎 Supersaturation ratio - 
𝜏𝑗 Residence time in the 𝑗
𝑡ℎ segment s 
𝜏𝑡𝑜𝑡𝑎𝑙 Total residence time of the crystallizer array s 
𝜑 Dissolution acceleration - 
𝜔𝑠𝑒𝑒𝑑 Standard deviation of seed distribution Gaussian 
bell curve 
m 
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